AEON Biopharma, Inc. (AEON)

ASE – Real Time Price. Currency in USD

0.28

+0.00 (1.38%)

Market open: Aug 12, 2026, 10:16 AM EDT

0.28

+0.01 (2.23%)

Previous after-hours: Aug 11, 2026, 7:38 PM EDT

03.08.2026

AEON Biopharma Regains Compliance with NYSE American Continued Listing Standards

ALISO VIEJO, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE American: AEON), a biopharmaceutical company advancing ABP-450 as a biosimilar to BOTOX® (onabotulinumtoxinA) for therapeutic use to achieve full-label U.S. market entry, today announced that it has received written notice from NYSE American LLC (“NYSE American”) confirming that AEON has regained compliance with NYSE American's continued listing standards relating to stockholders' equity.

Videos

No Data

There is no data to display

Upgrades / Downgrades

Ticker	Brokerage Firm	Ratings Change	Price Target	Date
AEON	Lake Street	Buy	undefined >> $1	July 30th 2026

Press releases

03.08.2026

AEON Biopharma, Inc. (AEON)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

AEON Biopharma, Inc. (AEON)

AEON Biopharma Regains Compliance with NYSE American Continued Listing Standards

Videos

No Data

Upgrades / Downgrades

Press releases

AEON Biopharma Regains Compliance with NYSE American Continued Listing Standards

AEON Biopharma Regains Compliance with NYSE American Continued Listing Standards

Videos

No Data

Upgrades / Downgrades

Press releases

AEON Biopharma Regains Compliance with NYSE American Continued Listing Standards

Search stocks

AEON Biopharma, Inc. (AEON)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

AEON Biopharma, Inc. (AEON)

AEON Biopharma Regains Compliance with NYSE American Continued Listing Standards

Videos

No Data

Upgrades / Downgrades

Press releases

AEON Biopharma Regains Compliance with NYSE American Continued Listing Standards

AEON Biopharma Regains Compliance with NYSE American Continued Listing Standards

Videos

No Data

Upgrades / Downgrades

Press releases

AEON Biopharma Regains Compliance with NYSE American Continued Listing Standards